Module

Treatment of Localized Disease

Source: Prostate Cancer Annual Update 2006

Treatment of Localized Disease

Program Director: E. David Crawford, MD

Faculty:
James A. Eastham, MD

CME CREDIT INFORMATION

Release Date: 03/22/06

Expiration Date: 03/21/07

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Registered Nurses: 1.3 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Review recent developments for assessing risk in patients with newly diagnosed, clinically localized prostate cancer
Describe factors affecting disease prognosis
Evaluate newer treatment strategies for localized disease, including active surveillance and focal therapy

Topics covered include:

Introduction
Assessing Patient Risk at the Time of Diagnosis
Newer Treatment Options for Localized Prostate Cancer: Active Surveillance
Newer Treatment Options for Localized Prostate Cancer: Focal Therapy
Recent Outcomes With Established Therapies
Strategies to Improve Sexual Function
Summary—Implications for Clinical Practice

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.